Literature DB >> 1795626

Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies.

P Mastroeni1, A Arena, G B Costa, M C Liberto, L Bonina, C E Hormaeche.   

Abstract

Tumour necrosis factor alpha (TNF alpha) was detected by the L929 cell assay in the sera of mice 1 h after large i.v. inocula of virulent Salmonella typhimurium C5. TNF alpha was not detectable in sera from innately susceptible BALB/c mice during the course of a lethal infection commencing from a low inoculum, or from resistant A/J mice during the course of a lethal or sublethal infection, but only 1 h after i.v. challenge with large numbers of organisms. Administration of a single dose of rabbit polyclonal anti-TNF alpha antiserum on day 1 had no effect on the early course of a lethal infection in A/J mice. However, the same treatment exacerbated a sublethal infection in A/J mice. Anti-TNF alpha treatment did not accelerate the early bacterial net growth rate in the RES. Instead, the cfu count in treated mice continued to increase past the point at which the host response suppressed a further increase in bacterial numbers (the plateau phase) in normal controls. A second dose of anti-TNF alpha antiserum on day 4 together with a higher but still sublethal challenge caused a lethal infection in A/J mice. The results indicate that TNF alpha is important in mediating the plateau phase in a salmonella infection, and its effect may be local.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1795626     DOI: 10.1016/0882-4010(91)90091-n

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  37 in total

1.  Role for neutrophils in host immune responses and genetic factors that modulate resistance to Salmonella enterica serovar typhimurium in the inbred mouse strain SPRET/Ei.

Authors:  Lien Dejager; Iris Pinheiro; Pieter Bogaert; Liesbeth Huys; Claude Libert
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 2.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

Review 3.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

4.  Toxicity of lipopolysaccharide and of soluble extracts of Salmonella typhimurium in mice immunized with a live attenuated aroA salmonella vaccine.

Authors:  P Mastroeni; B Villarreal-Ramos; J A Harrison; R Demarco de Hormaeche; C E Hormaeche
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections.

Authors:  P Mastroeni; J N Skepper; C E Hormaeche
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 6.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii.

Authors:  O Kandil; J A Fishman; H Koziel; P Pinkston; R M Rose; H G Remold
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Role of gamma interferon in late stages of murine salmonellosis.

Authors:  A Muotiala; P H Mäkelä
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection.

Authors:  T Arai; K Hiromatsu; H Nishimura; Y Kimura; N Kobayashi; H Ishida; Y Nimura; Y Yoshikai
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

10.  Dexamethasone modulates Salmonella enterica serovar Typhimurium infection in vivo independently of the glucocorticoid-inducible protein annexin-A1.

Authors:  Tomoko Smyth; Sabine Tötemeyer; Sean Haugland; Chrissie Willers; Sarah Peters; Duncan Maskell; Clare Bryant
Journal:  FEMS Immunol Med Microbiol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.